INNOVATION

Originator of Entrectinib and other innovative molecules

ABOUT US

Fully integrated platform for R&D value chain

MISSION

“Shaping oncology innovation”. Our commitment.

RESULTS

Proved track record, high quality standards and fully compliant services.

INTELLECTUAL PROPERTY

High value organization for oncology innovation

Delivering innovative drugs and high quality CRO e CDMO services

Mission

The mission of NMS Group is to discover and develop new molecules and therapeutic strategies, contributing to shape the future of cancer care. Thanks to its unique fully integrated R&D chain, the Group is also committed in offering high quality pre-clinical, clinical and production services at a global level.
The vast scientific heritage of internal skills, technology and experience represents our excellence and the basis for achieving our goals with continuous commitment and enthusiasm.

Unique fully integrated
R&D chain

High potential pipeline and robust R&D capabilities

Industrial innovation and
worldwide
patenting strategy

Licensing and alliances
opportunities

Innovative payloads platform and R&D tools

Proved track record

High quality standard and
fully compliant services

Several strategic scientific collaborations and training

NMS Group is the largest company in Italy committed in innovation and research and development in oncology.

About us

Our company is a high value organization covering the whole R&D process: from pre-clinical phase of research, to First-Time-In-Man of clinical phase, up to production and packaging of the finished drug. Nerviano Medical Sciences represents the innovative heart of the Group and make it an important and international reference in the field of personalized therapy. NMS Group also provides Research and Production services, addressed to local and international markets through three different companies: Accelera, one of the few companies engaged in preclinical research in Italy; Clioss engaged in clinical development starting from First-Time-In-Man and Nerpharma, dealing with activities from formulation to production of the active principle.

Discovery Nerviano Medical Sciences Srl

Preclinical Research Accelera Srl

Manufacturing Nerpharma Srl

Member of Lombardia life sciences